NorthWest Biotherapeutics Inc (NWBO)

[jesster64]

Just curious, but why would you print this
"There has been significant criticism of the study conduct since it shifted its primary endpoint from progression-free survival,"
yet not mention the over 70 peers in the JAMA article that concluded results were good? Is it possible the criticisms came from competing companys or physicians with ulterior motives? A lot of vague statements without doing due diligence. I believe Danish dude researched and wrote extensively on many of those naysayers with positions in competing companys.

Also, why did you not just report the facts? Instead, you added " I continue to hold a "Sell" sentiment at these levels.", putting a hit piece spin the whole article.